NCT00062686View on ClinicalTrials.gov

GW572016 For Treatment Of Refractory Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Neoplasms, Breast
Interventions
DRUG

GW572016

Trial Locations (7)

86150

GSK Investigational Site, Augsburg

94805

GSK Investigational Site, Villejuif

C1455BWU

GSK Investigational Site, Buenos Aires

SM2 5PT

GSK Investigational Site, Sutton

CH63 4JY

GSK Investigational Site, Bebington, Wirral

SW3 6JJ

GSK Investigational Site, London

M20 4BX

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00062686 - GW572016 For Treatment Of Refractory Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter